Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124185104 | 12418510 | 4 | F | 20131008 | 20160720 | 20160531 | 20160727 | EXP | JP-ASTRAZENECA-2016SE56994 | ASTRAZENECA | 24224.00 | DY | F | Y | 68.00000 | KG | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124185104 | 12418510 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 0 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 124185104 | 12418510 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 0 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QD | ||||||
| 124185104 | 12418510 | 3 | C | ANTIHYPERTENSIVES | UNSPECIFIED INGREDIENT | 1 | Oral | DOSE UNKNOWN | 0 | TABLET | |||||||||
| 124185104 | 12418510 | 4 | C | CADUET | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 124185104 | 12418510 | 5 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 124185104 | 12418510 | 6 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 124185104 | 12418510 | 7 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | 2 | MG | TABLET | BID | |||||||
| 124185104 | 12418510 | 8 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 250 | MG | TABLET | TID | |||||||
| 124185104 | 12418510 | 9 | C | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124185104 | 12418510 | 1 | Type 2 diabetes mellitus |
| 124185104 | 12418510 | 2 | Type 2 diabetes mellitus |
| 124185104 | 12418510 | 4 | Hypertension |
| 124185104 | 12418510 | 5 | Dyslipidaemia |
| 124185104 | 12418510 | 6 | Hypertension |
| 124185104 | 12418510 | 7 | Type 2 diabetes mellitus |
| 124185104 | 12418510 | 8 | Type 2 diabetes mellitus |
| 124185104 | 12418510 | 9 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124185104 | 12418510 | OT |
| 124185104 | 12418510 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124185104 | 12418510 | Aortic calcification | |
| 124185104 | 12418510 | Hepatic cyst | |
| 124185104 | 12418510 | Hepatic steatosis | |
| 124185104 | 12418510 | Hyperplastic cholecystopathy | |
| 124185104 | 12418510 | Metastases to liver | |
| 124185104 | 12418510 | Nausea | |
| 124185104 | 12418510 | Pancreatic carcinoma metastatic | |
| 124185104 | 12418510 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124185104 | 12418510 | 1 | 20110406 | 20131007 | 0 | |
| 124185104 | 12418510 | 2 | 20131008 | 0 |